Private Equity Firm Profile
In the last 3 years, ArchiMed has acquired 7 companies. It has also invested in 2 others.
ArchiMed’s most common sectors for investment arelife science (31%) and medical products (31%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (58%) and secondary buyout (20%). In total, ArchiMed has invested in 5 US states and 10 different countries. Its largest (disclosed) acquisition occurred in 2022 when it acquired Natus Medical for $1.1B.
In the last 3 years, ArchiMed has exited 4 companies. The Firm’s most common exit type is trade sale (80%). ArchiMed’s largest (disclosed) exit occurred in 2023 when it sold Polyplus-transfection SA for $2.7B.
Join Mergr to view ArchiMed’s full profile and discover more middle-market private equity firm investors just like it.
M&A Summary
-
M&A Total Activity31
- M&A Buy Activity26
- M&A Sell Activity5
- Total Sectors Invested 8
- Total Countries Invested 10
- M&A Buy/Sell Connections 6
- M&A Advisors 3